*Leading genome engineering solutions provider announces expanded availability of the most efficient and cost effective synthetic RNA to the UK*

REDWOOD CITY, CA and LONDON, UNITED KINGDOM–(Marketwired – Apr 4, 2017) – Synthego , a leading provider of genome engineering solutions, today announces the University of Oxford has been chosen for its synthetic sgRNA grant as Synthego launches expanded product availability in the UK. The University of Oxford, selected for its novel research applications in bladder cancer, was one of eight institutions chosen for the exclusive grant from Synthego, which totaled $160,000 in synthetic sgRNA to help scientists more effectively conduct CRISPR gene editing research.